Sign in

Filings

Finds words inside filing documents. Searching Atara Biotherapeutics, Inc.'s filings · 42 documents indexed.

9 documents · 50 matches

  1. ATRA Atara Biotherapeutics, Inc. 10-K 2026-03-16

    Item 8. Financial Statements and Supplementary Data

    going concern. As discussed in Note 2 to the financial statements, the Company’s negative cash flow from operations and losses
    8 matches in this document
  2. ATRA Atara Biotherapeutics, Inc. 10-Q 2026-08-12

    Item 6.

    going concern, we plan to secure additional capital, potentially through a combination of public or private security offerings; use of our ATM facility
    6 matches in this document
  3. ATRA Atara Biotherapeutics, Inc. 10-Q 2026-05-12

    Item 6.

    going concern, we plan to secure additional capital, potentially through a combination of public or private security offerings; use of our ATM facility
    6 matches in this document
  4. ATRA Atara Biotherapeutics, Inc. 10-Q 2025-08-11

    Item 6.

    going concern, we plan to secure additional capital, potentially through a combination of public or private security offerings; use of our ATM facility
    6 matches in this document
  5. ATRA Atara Biotherapeutics, Inc. S-3 2026-11-10

    that our existing capital resources will be sufficient to enable us to fund our planned operations, including our going concern assessment;
    2 matches in this document
  6. ATRA Atara Biotherapeutics, Inc. 10-Q 2026-11-10

    Item 6.

    that our existing capital resources will be sufficient to enable us to fund our planned operations, including our going concern assessment;
    7 matches in this document
  7. ATRA Atara Biotherapeutics, Inc. 8-K 2026-11-10

    going concern and access capital, and the sufficiency of Atara’s cash resources and access to additional capital on favorable
    1 match in this document
  8. ATRA Atara Biotherapeutics, Inc. 10-Q 2025-11-12

    Item 6.

    that our existing capital resources will be sufficient to enable us to fund our planned operations, including our going concern assessment;
    7 matches in this document
  9. ATRA Atara Biotherapeutics, Inc. 10-Q 2025-05-15

    Item 6.

    that our existing capital resources will be sufficient to enable us to fund our planned operations, including our going concern assessment;
    7 matches in this document

Page 1 of 1 · 9 documents